Device Trial Radar · NCT05528939
Feasibility/Acceptability of Attentional-Control Training in Survivors
Last checked: Nov 20, 2026Latest source record: Jan 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
50
Planned (sponsor's estimate)
Start
Jun 14, 2023
Primary completion
Aug 31, 2025
Study completion Aug 31, 2025
Sponsor
- Lead sponsor
- Children's National Research InstituteAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- St. Jude Children's Research Hospital; Children's Hospital of Philadelphia; George Washington University; National Cancer Institute (NCI)
- First posted
- Sep 6, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 8 years, up to 16 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter pilot randomized controlled trial, with an active control condition, of the feasibility, acceptability, and preliminary efficacy of EndeavorRx in a cohort of survivors of acute lymphoblastic leukemia or brain tumor ages 8-16 who are \> 1 year from the end of therapy.
Conditions
- Pediatric Cancer
- Pediatric ALL
- Pediatric Brain Tumor
- Attention Difficulties
- Cognitive Deficit in Attention
Interventions
EndeavorRxDevice
EndeavorRx is a digital intervention delivered through an action video game that is indicated to improve attention function. EndeavorRx users first complete two discrete tasks: 1) a perceptual discrimination/attention task in which users respond to target stimuli and ignore distractor stimuli (e.g., tapping the screen quickly only when red aliens appear) and 2) a sensorimotor navigation task in which users tilt their device to steer a hovercraft down a river while targeting or avoiding certain objects. Users are subsequently presented with a multitask training session where they complete the perceptual discrimination/attention task and the sensorimotor navigation task simultaneously. Algorithms adapt the program in both real-time and between sessions to automatically adjust the difficulty level.
Control video gameOther
The active control program, used in previous studies of this intervention, was designed to match EndeavorRx on expectancy, engagement, and time on task in the form of a challenging and engaging digital word game, targeting cognitive domains not targeted by EndeavorRx and not primarily associated with attentional difficulties. Users are instructed to find and connect letters on a grid to spell words; points are awarded based on number of words formed, word length, and the use of unusual letters. There is progression in difficulty to maintain engagement and expectation of benefit from patients and their caregivers.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Feasibility assessed by patient/family interestTime frame: Baseline
- Feasibility assessed by EndeavorRx training adherence ratesTime frame: After completion of 4 weeks of EndeavorRx training
- Feasibility assessed by reports of technical ease-of-use and satisfactionTime frame: End of training (+4 weeks)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Children's National Hospital
Washington D.C., District of Columbia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.